MEDICAL MARIJUANA

Court Backs Florida Medical Cannabis Patients’ Gun Rights 0
- MEDICAL MARIJUANA
- August 22, 2025
In a major federal appeals court decision, Florida medical cannabis patients won a significant victory for Second Amendment rights. On August 20, 2025, the Eleventh Circuit Court of Appeals ruled that individuals registered with Florida’s medical marijuana program cannot be automatically denied the right to purchase or possess firearms solely based on their medicinal cannabis
READ MORE
Texas Expands Medical Marijuana Access with More Qualifying Conditions 0
- MEDICAL MARIJUANA
- August 14, 2025
Texas has broadened its medical cannabis program, allowing more patients with chronic pain and serious conditions to qualify for treatment under the state’s low-THC framework. Unlike recreational markets, Texas restricts products to less than 0.5% THC and limits prescribing to registered physicians, with dispensing tightly regulated. Patients won’t find smokable flower; instead, approved options include
READ MORE
Eight Emerging Uses for Medical Cannabis: A 2025 Overview 0
- MEDICAL MARIJUANA
- August 7, 2025
Medical cannabis is gaining traction for treating a diverse range of health conditions, bolstered by loosening regulations and evolving medical research. As of August 2025, the Drug Enforcement Administration (DEA) is moving toward reclassifying marijuana from a Schedule I to a Schedule III drug, although the process remains incomplete. Despite ongoing federal restrictions, cannabis is
READ MORE

Pennsylvania Bill Proposes Workers’ Comp Coverage for Medical Marijuana 0

A new bill introduced in Pennsylvania aims to require employers to reimburse injured workers for medical cannabis prescribed under the state’s medical marijuana program. Sponsored by Rep. David Delloso (D), the proposal would cover up to $250 per month and a maximum of $3,000 annually for qualifying patients, offering an alternative to opioids for pain

THC-CBD Cannabis Combination Shows Strongest Migraine Relief in Landmark Study 0

A new placebo-controlled trial presented at the American Headache Society reveals that vaporized cannabis—especially a combination of THC and CBD—offers significant relief for migraine sufferers. In the study, over two-thirds of participants reported pain relief two hours after using either THC (68.9%) or a THC–CBD combination (67.2%), while only 46.6% experienced relief with a placebo.

Major Health Groups Urge Congress to Safeguard State Medical Marijuana Laws 0

A coalition of 45 leading health and advocacy organizations, including Americans for Safe Access, the National Multiple Sclerosis Society, and the Epilepsy Foundation of America, is urging Congress to maintain federal protections for state medical marijuana programs. These groups sent a letter to House and Senate appropriations leaders, emphasizing that the annual spending bill should